SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function-Reference-Cited by-同舟云学术

SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function

Published:2019-08 Issue: Volume:133 Page:125-137
ISSN:0022-2828
Container-title:Journal of Molecular and Cellular Cardiology
language:en
Short-container-title:Journal of Molecular and Cellular Cardiology

Author:

Wang Panxia,Wang Luping,Lu Jing^ORCID,Hu Yuehuai,Wang Qianqian,Li Zhenzhen,Cai Sidong,Liang Liying,Guo Kaiteng,Xie Jiyan,Wang Junjian,Lan Rui,Shen Juan,Liu Peiqing^ORCID

Funder

National Natural Science Foundation of China

Indigenous Innovative Research Team of Guangdong Province

Creation and Manufacture of New Drugs

Applied Science and Technology of Guangdong Province

National Engineering and Technology Research Center for New drug Druggability Evaluation

Guangzhou Science and Technology

Medical Scientific Research Foundation of Guangdong Province

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Molecular Biology

Reference81 articles.

1. Doxorubicin: the good, the bad and the ugly effect;Carvalho;Curr. Med. Chem.,2009

2. Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies;Octavia;J. Mol. Cell. Cardiol.,2012

3. Doxorubicin-induced mitophagy and mitochondrial damage is associated with dysregulation of the PINK1/parkin pathway;Yin;Toxicol. in Vitro,2018

4. Identification of the molecular basis of doxorubicin-induced cardiotoxicity;Zhang;Nat. Med.,2012

5. A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine;Myers;Semin. Oncol.,1983

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of doxorubicin-induced cardiac inflammation and fibrosis; therapeutic targets and approaches;Archives of Biochemistry and Biophysics;2024-09

2. Ohwia caudata inhibits doxorubicin‐induced cardiotoxicity by regulating mitochondrial dynamics via the IGF‐IIR/p‐Drp1/PARP signaling pathway;Biotechnology and Applied Biochemistry;2024-06-04

3. Follistatin-like protein 1 attenuates doxorubicin-induced cardiomyopathy by inhibiting MsrB2-mediated mitophagy;Molecular and Cellular Biochemistry;2024-05-02

4. AP39 through AMPK-ULK1-FUNDC1 pathway regulates mitophagy, inhibits pyroptosis, and improves doxorubicin-induced myocardial fibrosis;iScience;2024-04

5. Follistatin‐like 1 protects against doxorubicin‐induced cardiotoxicity by preventing mitochondrial dysfunction through the SIRT6/Nrf2 signaling pathway;Cell Biology International;2024-03-04